tazarotene has been researched along with 1 alpha,24-dihydroxyvitamin d3 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hönigsmann, H; Seeber, A; Tanew, A; Tzaneva, S | 1 |
| Bruner, CR; Feldman, SR; Fleischer, AB; Ventrapragada, M | 1 |
1 review(s) available for tazarotene and 1 alpha,24-dihydroxyvitamin d3
| Article | Year |
|---|---|
A systematic review of adverse effects associated with topical treatments for psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Dermatologic Agents; Dihydroxycholecalciferols; Drug Therapy, Combination; Erythema; Humans; Nicotinic Acids; Pain; Pruritus; Psoriasis; Vitamin D | 2003 |
1 trial(s) available for tazarotene and 1 alpha,24-dihydroxyvitamin d3
| Article | Year |
|---|---|
A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
Topics: Adult; Chronic Disease; Combined Modality Therapy; Dermatologic Agents; Dihydroxycholecalciferols; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Acids; Psoriasis; PUVA Therapy; Radiation Dosage; Severity of Illness Index | 2002 |